Young adults hit hardest by heat in Mexico, new study shows

Physicians should not engage in fundraising efforts that directly solicit patients for donations — a practice known as grateful patient fundraising — due to ethical

Bris­tol My­ers Squibb and 2sev­en­ty bio said this week that a man­u­fac­tur­ing shut­down will trans­late to low­er-than-ex­pect­ed sales for their CAR-T cell ther­a­py Abec­ma in

Up until fairly recently, ruxolitinib (Jakafi) was the only FDA-approved treatment for intermediate- and high-risk myelofibrosis, and thus has been the cornerstone of myelofibrosis treatment